Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $3.2 million.

  • TransMedics' Other Non Operating Income fell 1820.26% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year decrease of 3016.88%. This contributed to the annual value of $12.7 million for FY2024, which is 119.87% down from last year.
  • TransMedics' Other Non Operating Income amounted to $3.2 million in Q3 2025, which was down 1820.26% from $3.1 million recorded in Q2 2025.
  • TransMedics' 5-year Other Non Operating Income high stood at $5.0 million for Q3 2023, and its period low was -$1.1 million during Q3 2022.
  • In the last 5 years, TransMedics' Other Non Operating Income had a median value of $1.9 million in 2024 and averaged $1.7 million.
  • As far as peak fluctuations go, TransMedics' Other Non Operating Income tumbled by 55847.95% in 2022, and later surged by 56431.23% in 2023.
  • Over the past 5 years, TransMedics' Other Non Operating Income (Quarter) stood at -$345000.0 in 2021, then surged by 414.49% to $1.1 million in 2022, then surged by 348.39% to $4.9 million in 2023, then plummeted by 60.62% to $1.9 million in 2024, then surged by 68.16% to $3.2 million in 2025.
  • Its Other Non Operating Income stands at $3.2 million for Q3 2025, versus $3.1 million for Q2 2025 and $2.7 million for Q1 2025.